高级搜索

酸性富含半胱氨酸分泌型蛋白表达与食管鳞癌术后预后的相关性

黄海波, 刘凯, 赵燕, 郭永军, 刘艳艳, 杨树军

黄海波, 刘凯, 赵燕, 郭永军, 刘艳艳, 杨树军. 酸性富含半胱氨酸分泌型蛋白表达与食管鳞癌术后预后的相关性[J]. 肿瘤防治研究, 2016, 43(1): 35-38. DOI: 10.3971/j.issn.1000-8578.2016.01.008
引用本文: 黄海波, 刘凯, 赵燕, 郭永军, 刘艳艳, 杨树军. 酸性富含半胱氨酸分泌型蛋白表达与食管鳞癌术后预后的相关性[J]. 肿瘤防治研究, 2016, 43(1): 35-38. DOI: 10.3971/j.issn.1000-8578.2016.01.008
HUANG Haibo, LIU Kai, ZHAO Yan, GUO Yongjun, LIU Yanyan, YANG Shujun. Relationship of Secreted Protein Acidic and Rich in Cysteine Protein Expression with Prognosis of Postoperative Patients with Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2016, 43(1): 35-38. DOI: 10.3971/j.issn.1000-8578.2016.01.008
Citation: HUANG Haibo, LIU Kai, ZHAO Yan, GUO Yongjun, LIU Yanyan, YANG Shujun. Relationship of Secreted Protein Acidic and Rich in Cysteine Protein Expression with Prognosis of Postoperative Patients with Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2016, 43(1): 35-38. DOI: 10.3971/j.issn.1000-8578.2016.01.008

酸性富含半胱氨酸分泌型蛋白表达与食管鳞癌术后预后的相关性

详细信息
    作者简介:

    黄海波(1987-),女,硕士,医师,主要从事肿瘤内科疾病研究与治疗

    通讯作者:

    杨树军,E-mail: NKyang@126.com

  • 中图分类号: R735.1

Relationship of Secreted Protein Acidic and Rich in Cysteine Protein Expression with Prognosis of Postoperative Patients with Esophageal Squamous Cell Carcinoma

  • 摘要: 目的 探讨食管鳞癌患者中酸性富含半胱氨酸分泌型蛋白(SPARC)表达与术后临床特征及预后的相关性。方法 随机选择在郑州大学附属肿瘤医院行手术治疗的初诊食管鳞癌患者89例,收集肿瘤标本和癌旁正常组织,应用免疫组织化学法检测SPARC蛋白的表达,统计分析其与患者临床特征和预后的相关性。结果 食管鳞癌组织SPARC蛋白阳性表达率显著高于癌旁组织(65.17% vs.8.00%, P=0.000),SPARC蛋白优势定位于肿瘤细胞间质中。SPARC蛋白表达与术后淋巴结转移呈负相关(OR=0.369, P=0.038),与病理大体形态、肿瘤分化程度和其他临床特征无关。食管鳞癌患者术后生存与SPARC蛋白表达无关(HR=0.80, P=0.691),而与肿瘤部位(HR=0.34, P=0.037)、分化程度(HR=4.12, P=0.000)和分期(HR=6.36, P=0.017)有关。结论 SPARC蛋白在食管鳞癌间质中高表达,与淋巴结转移负相关,与食管鳞癌术后生存无关。

     

    Abstract: Objective To explore the correlation between the expression of secreted protein acidic and rich in cysteine(SPARC) and the prognosis of postoperative patients with esophageal squamous cell carcinoma(ESCC). Methods Eighty-nine postoperative patients with ESCC treated in the Affiliated Cancer Hospital of Zhengzhou University were included in the investigation. The expression of SPARC protein was detected in ESCC specimen and normal esophageal mucosa by immunohistochemistry method. The relationship of SPARC protein expression with patients' clinical characteristics and prognosis was analyzed statistically. Results The expression of SPARC protein was significantly up-regulated in ESCC sample compared with normal esophageal mucosa (65.17% vs. 8.00%, P=0.000), and predominately located in tumor stroma. SPARC protein expression was negatively correlated with lymph node metastasis (OR=0.369, P=0.038) while it was not related with gross morphology, differentiation grade or other clinical characteristics. Postoperative patient survival was not associated with SPARC protein expression (HR=0.80, P=0.691), but it was related with tumor site (HR=0.34, P=0.037), differentiation grade (HR=4.12, P=0.000) and stage (HR=6.36, P=0.017). Conclusion SPARC protein dominantly expresses in the stroma of ESCC. It is negatively related with lymph node metastasis and does not display the association with the prognosis of postoperative ESCC patients.

     

  • [1] Chlenski A, Cohn SL. Modulation of matrix remodeling by SPARC in neoplastic progression[J]. Semin Cell Dev Biol, 2010, 21(1): 55 -65.
    [2] Nagaraju GP, Dontula R, El-Rayes BF, et al. Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis[J]. Carcinogenesis, 2014, 35(5): 967-73.
    [3] Nagaraju GP, Sharma D. Anti-cancer role of SPARC, an inhibitor of adipogenesis[J]. Cancer Treat Rev, 2011, 37(7): 559-66.
    [4] Che YQ, Wang H, Qi J, et al. The analysis of the SPARC protein expression and clinical significance in esophageal squamous cell carcinoma[J]. Zhongguo Zhong Liu Lin Chuang, 2006, 33(2): 61 -3. [车轶群, 王海, 齐军, 等. 食管鳞癌组织中SPARC蛋白表 达的临床意义[J]. 中国肿瘤临床, 2006, 33(2): 61-3.]
    [5] Yang XG, Jiang C, Liu F, et al. SPARC protein expression and clinical significance in esophageal squamous cell carcinoma[J]. Zhong Liu Fang Zhi Yan Jiu, 2012, 39(10): 1240-2. [杨锡贵, 姜 超, 刘封, 等. SPARC 蛋白在食管鳞癌组织中的表达及临床意 义[J] 肿瘤防治研究, 2012, 39(10): 1240-2.]
    [6] Yang XG, Giang C, Liu F, et al. The relationship between SPARC protein expression and the survival in esophageal squamous cell carcinoma[J]. Zhonghua Xiao Hua Za Zhi, 2013, 33(3): 197-8. [杨 锡贵, 姜超, 刘封, 等. 食管鳞状细胞癌组织中酸性富含半胱氨 酸分泌型蛋白的表达与生存的相关性[J]. 中华消化杂志, 2013, 33 (3): 197-8.]
    [7] Xue LY, Hu N, Song YM, et al. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma[J]. BMC Cancer, 2006, 6: 296.
    [8] Porte H, Triboulet JP, Kotelevets L, et al. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis[J]. Clin Cancer Res, 1998, 4(6): 1375-82.
    [9] Tang L, Feng J. SPARC in tumor pathophysiology and as a potential therapeutic target[J]. Curr Pharm Des, 2014, 20(39): 61 82-90.
    [10] Derosa CA, Furusato B, Shaheduzzaman S, et al. Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression[J]. Prostate Cancer Prostatic Dis, 2012, 15 (2): 150-6.
    [11] Miyoshi K, Sato N, Ohuchida K, et al. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients[J]. Anticancer Res, 2010, 30(3): 867-71.
    [12] Xue LY, Zou SM, Zheng S, et al. Expressions of the γ2 chain of laminin-5 and secreted protein acidic and rich in cysteine in esophageal squamous cell carcinoma and their relation to prognosis[J]. Chin J Cancer, 2011, 30(1): 69-78.
    [13] Thota R, Pauff JM, Berlin JD. Treatment of metastatic pancreatic adenocarcinoma: a review[J]. Oncology (Williston Park), 2014, 28 (1): 70-4.
计量
  • 文章访问数:  1332
  • HTML全文浏览量:  331
  • PDF下载量:  308
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-03-01
  • 修回日期:  2015-09-15
  • 刊出日期:  2016-01-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭